Heart conditions

Every manufacturer places this the same way.

scroll for all 10 products →

Which section of each manufacturer's label carries this concept
Section	Brown & Burk UK Ltd10mg Tablets	Strides Pharma UK Ltd10mg Tablets	Flamingo Pharma (UK) Ltd10mg Tablets	Wockhardt UK Ltd10mg/5ml Oral Solution	Flamingo Pharma (UK) Ltd25mg Tablets	Wockhardt UK Ltd25mg/5ml Oral Solution	Wockhardt UK Ltd50mg/5ml Oral Solution	Rosemont Pharmaceuticals Limited50mg/5ml Oral Solution	Amarox Limited10mg Tablets	SyriMed10mg/5ml Oral Solution
ContraindicatedThe label says it must not be used.	Contraindicated	Contraindicated	Contraindicated	Contraindicated	Contraindicated	Contraindicated	Contraindicated	Contraindicated	Contraindicated	Contraindicated
WarningThe label says it can be used, with care.
InteractionThe label says another medicine affects it.
PregnancyThe label gives advice for pregnancy or breastfeeding.
ExcipientThe label lists it as an ingredient, not a restriction.

Contraindicated
- Brown & Burk UK Ltd
  10mg Tablets · revised 26/03/2025
  93–214 of 842 characters
  Source SmPC ↗
- Strides Pharma UK Ltd
  10mg Tablets · revised 01/09/2025
  93–214 of 841 characters
  Source SmPC ↗
- Flamingo Pharma (UK) Ltd
  10mg Tablets · revised 30/06/2025
  93–214 of 841 characters
  Source SmPC ↗
- Wockhardt UK Ltd
  10mg/5ml Oral Solution · revised 30/04/2025
  93–214 of 840 characters
  Source SmPC ↗
- Flamingo Pharma (UK) Ltd
  25mg Tablets · revised 04/11/2025
  93–214 of 841 characters
  Source SmPC ↗
- Wockhardt UK Ltd
  25mg/5ml Oral Solution · revised 30/04/2025
  93–214 of 840 characters
  Source SmPC ↗
- Wockhardt UK Ltd
  50mg/5ml Oral Solution · revised 30/04/2025
  93–214 of 840 characters
  Source SmPC ↗
- Rosemont Pharmaceuticals Limited
  50mg/5ml Oral Solution · revised 01/04/2025
  94–215 of 844 characters
  Source SmPC ↗
- Amarox Limited
  10mg Tablets · revised 03/06/2025
  103–224 of 866 characters
  Source SmPC ↗
- SyriMed
  10mg/5ml Oral Solution · revised 09/12/2025
  93–214 of 841 characters
  Source SmPC ↗
Hypersensitivity to the active substance or to any of the excipients listed in section 6.1. Recent myocardial infarction. Any degree of heart block or disorders of cardiac rhythm and coronary artery insufficiency. Concomitant treatment with MAOIs (monoamine oxidase inhibitors) is contra-indicated (see section 4.5). Simultaneous administration of amitriptyline and MAOIs may cause serotonin syndrome (a combina
Identical in all 10 labels. Surrounding text shown from Brown & Burk UK Ltd.